Aldeyra Therapeutics, Inc. financial data

Symbol
ALDX on Nasdaq
Industry
Pharmaceutical Preparations
Location
131 Hartwell Avenue, Suite 320, Lexington, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Aldexa Therapeutics, Inc. (to 3/4/2014), Neuron Systems Inc (to 8/1/2008)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 573 % -30.1%
Debt-to-equity 33 % +53.7%
Return On Equity -33.8 %
Return On Assets -45.7 % -88.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.7M shares +1.38%
Common Stock, Shares, Outstanding 59.6M shares +0.76%
Entity Public Float 192M USD -60.3%
Common Stock, Value, Issued 59.6K USD +0.76%
Weighted Average Number of Shares Outstanding, Basic 59.5M shares +0.92%
Weighted Average Number of Shares Outstanding, Diluted 59.5M shares +0.92%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 48.2M USD +63.7%
General and Administrative Expense 11.9M USD -10.8%
Operating Income (Loss) -60.1M USD -40.5%
Nonoperating Income (Expense) 4.27M USD -18.8%
Net Income (Loss) Attributable to Parent -55.9M USD -48.8%
Earnings Per Share, Basic -0.94 USD/shares -46.9%
Earnings Per Share, Diluted -0.94 USD/shares -46.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 54.5M USD
Marketable Securities, Current 46.6M USD
Other Assets, Current 0 USD -100%
Assets, Current 104M USD -29.6%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 267K USD -47.7%
Assets 105M USD -29.5%
Accounts Payable, Current 180K USD -86.5%
Employee-related Liabilities, Current 4.33M USD +40.3%
Accrued Liabilities, Current 12.1M USD +119%
Liabilities, Current 18.6M USD -16.4%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 33.6M USD +17.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 37.4K USD
Retained Earnings (Accumulated Deficit) -450M USD -14.2%
Stockholders' Equity Attributable to Parent 71M USD -40.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 123M USD
Liabilities and Equity 105M USD -29.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.97M USD -5.6%
Net Cash Provided by (Used in) Financing Activities 18.2K USD -65.4%
Net Cash Provided by (Used in) Investing Activities -30.4M USD -201%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 59.6M shares +0.76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -40.3M USD -296%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 54.5M USD -61.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 440K USD +10.7%
Deferred Tax Assets, Valuation Allowance 121M USD +15.9%
Deferred Tax Assets, Gross 122M USD +15.8%
Operating Lease, Liability 272K USD -46.8%
Depreciation 60.6K USD -9.47%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -55.8M USD -49.1%
Lessee, Operating Lease, Liability, to be Paid 285K USD -49.2%
Operating Lease, Liability, Current 272K USD +13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 285K USD +3.39%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.6K USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 80.8K USD -42.1%
Share-based Payment Arrangement, Expense 7.97M USD +38.6%
Interest Expense 2.03M USD +7.01%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%